"Antisurvival" factor treatment for hormone refractory prostate cancer: Secondary hormonal ablation using somatostatin analogs

David Schilling, Rainer Küfer, Stephan Kruck, Sandra Waalkes, Arnulf Stenzl, Markus A. Kuczyk, Axel S. Merseburger

Fingerprint

Dive into the research topics of '"Antisurvival" factor treatment for hormone refractory prostate cancer: Secondary hormonal ablation using somatostatin analogs'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Veterinary Science and Veterinary Medicine